Oct. 28, 2010 (Baystreet.ca) --
TORONTO, Canada - Ubika Research has issued a research report on the strategy update announced by Medworxx Solutions Inc (TSX VENTURE: MWX) (CVE: MWX) on Oct 18, 2010. The research update is titled " Leveraging patient flow leadership – New strategy to expand internationally”.
Medworxx is the leader in the growing field of patient flow products within the fast growing health care IT sector. Patient flow has emerged as a key area of focus in hospitals as countries grapple with spiralling health care costs, lack of enough hospital beds and the pressures of an ageing population with complex needs.
Medworxx has over 120 hospitals in Canada as its customers and this research update discusses Medworxx’s plan to grow internationally leveraging its leadership in this emerging growth area.
Medworxx Solutions Inc (TSXV: MWX) (CVE: MWX) is among the very few small cap publicly traded health care IT companies in Canada with real revenues and a solid blue chip customer base in health care vertical.
Download this research update and past reports on Medworxx at: http://www.smallcappower.com/microsite/medworxx_solutions_inc_research_reports.html
To view our CEO video interview with Medworxx President & CEO, Mr. Dan Matlow, please visit: http://www.smallcappower.com/microsite/medworxx_solutions_inc_videos.html
Sign up at www.smallcappower.com to receive free daily email on small cap stock picks, research and investment ideas.
www.smallcappower.com has now information and research reports on over 100 high quality small cap companies in a wide range of sectors such as metals & mining, gold, tech and clean tech.
About Ubika Research
Ubika Research is an investment research and capital market services firm based in Toronto and Vancouver. It provides comprehensive research, communication and capital market exposure program to highlight the investment potential in micro and small cap companies. For more information visit www.ubikaresearch.com
Disclosure
Except for the historical information presented herein, matters discussed in this document contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.
Ubika Research, a division of Ubika Corporation, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this report. For making specific investment decisions, readers should seek their own advice.
For full disclosure please visit:
http://www.smallcappower.com/microsite/medworxx_solutions_inc.html
For additional information contact:
Vishy Karamadam, Managing Director
Phone: 647-352-0666
Email: vishy@ubikacorp.com